Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Navatar Launches AI-Powered CRM Operating Model On Salesforce for Alternative Asset Managers
-
Whirlpool Corporation Announces Pricing of Upsized Concurrent Offerings of Common Stock and Depositary Shares
-
Changes to the Adecco Group Board of Directors
-
THE ADECCO GROUP Q4 & FULL YEAR 2025 RESULTS
-
The Ultimate Human Operating System: How We Are Engineering the Future of Youth Potential
-
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
-
FLSmidth: Transactions under share buy-back programme
-
Top 10 Reasons Dr. Kamal Woods is the “iPhone” of Spine Surgery (And Why You Need the Upgrade)
-
7 Reasons Why “Hope” Is Not a Valid Backup Strategy (And How to Actually Protect Your Digital Life)
-
Ashlee Fence Company Reports Shift in Market Trends: Why Aluminum Fencing Is Becoming the New Standard for Ohio Homes
-
Top 5 Updates from the Cable Bros HQ: What Our Recent Growth Means for Your Property
-
Children's Hospital of Philadelphia Marks One-Year Anniversary of World's First Personalized CRISPR Gene Therapy for Child with Rare Genetic Disease
-
IBM 2026 X-Force Threat Index: AI-Driven Attacks are Escalating as Basic Security Gaps Leave Enterprises Exposed
-
AIRS Medical to Showcase SwiftMR™ Live at ECR 2026
-
Polyplastics Develops New PLASTRON(R) LFT Grades with Post-consumer Recycled Content
-
Abbott Cooper PLLC Investigates Potential Breaches of Fiduciary Duty by MarketWise, Inc. Board of Directors
-
Fairfax’s John Foster Launches the 7-Day Clarity Challenge for Busy Professionals
-
PaintCare Illinois Hits Early Program Milestones in First Two Months
-
ALTA Applauds Focus on Housing Affordability, Emphasizes Need to Protect Homebuyers
-
Sir Patrick Bijou Highlights Long-Running Charitable Work and a Practical Model for Giving Back
-
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Abbott Cooper PLLC Investigates Potential Breaches of Fiduciary Duty by Lee Enterprises, Incorporated Board of Directors
-
Metalpha, Exos Financial, and BlockchainK2 Announce Joint Venture for US Institutional Digital Asset Market
-
Southern Innovation: Invitation to PDAC 2026 Booth 1345
-
Canton Fair to Launch Promotion Conference in South Korea for Its Upcoming Session
-
Trading Technologies to Provide Direct Connectivity to the National Stock Exchange of India
-
Litter pickup group set to open new park in Englewood by April
-
Intuitive Machines Announces Date for Fourth Quarter, Full-Year 2025 Financial Results, and Post-Lanteris Space Systems Acquisition Conference Call
-
Advantech's GMSL Camera Enablement Scheme with Expanded Eco-Partners Streamlining AMR, Humanoid, and Industrial Robots
-
HTX Expands Its Philanthropic Footprint: Connecting Global Kindness Through the "Punch Spirit"
-
Kuvare Holdings Comments on Recent Press Coverage Addressing Matters Involving Relationship with Blue Owl Capital
-
Tallgrass and Bridger Pipeline Announce a Joint Open Season from the Bakken for the Bridger and Seahorse Pipelines
-
Qingdao is Credited as One of the Top 10 Travel Destinations by International Friends During the Spring Festival Holiday 2026
-
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Tallgrass and Bridger Pipeline Announce a Joint Open Season from the Bakken for the Bridger and Pony Express Pipelines
-
Next Point Advises Endodontic Specialties of NEPA on Practice Transition
-
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
